Recent Finacing
Recent Raise
Highland Therapeutics, via subsidiary Ironshore, uses DELEXIS delivery technology to reformulate methylphenidate (HLD‑200) and amphetamine (HLD‑100) for nighttime dosing, conducting clinical development and manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors